360 related articles for article (PubMed ID: 18372321)
1. Medicare from A to D: what every nephrologist needs to know.
Morrison L
Clin J Am Soc Nephrol; 2008 May; 3(3):899-904. PubMed ID: 18372321
[No Abstract] [Full Text] [Related]
2. Extension of Medicare immunosuppressive drug benefits: a "no brainer" that did not happen.
Bennett WM
Clin J Am Soc Nephrol; 2010 May; 5(5):743. PubMed ID: 20448072
[No Abstract] [Full Text] [Related]
3. Drug coverage for transplantation turns into political football: big business trumps patients.
Cohen DJ; Murphy B
Clin J Am Soc Nephrol; 2010 May; 5(5):746-7. PubMed ID: 20448069
[No Abstract] [Full Text] [Related]
4. Staring into the abyss, or into the future.
Blaser R
Nephrol News Issues; 2013 Jan; 27(1):15-6. PubMed ID: 23427469
[No Abstract] [Full Text] [Related]
5. Special issues for younger Medicare beneficiaries with disabilities.
Burns B
Issue Brief Cent Medicare Educ; 2003; 4(2):1-8. PubMed ID: 12675050
[TBL] [Abstract][Full Text] [Related]
6. Medicare and long-term care.
Stein J
Issue Brief Cent Medicare Educ; 2003; 4(4):1-6. PubMed ID: 12836639
[TBL] [Abstract][Full Text] [Related]
7. Proposed conditions for coverage directed toward dialysis facilities.
Smetanka S
Health Care Law Mon; 2005 Apr; ():3-11. PubMed ID: 15895752
[No Abstract] [Full Text] [Related]
8. End stage renal disease.
Greer J
Health Care Financ Rev Annu Suppl; 1992; ():199-205. PubMed ID: 10131707
[No Abstract] [Full Text] [Related]
9. Medicare Part D: state and local efforts to assist vulnerable beneficiaries.
Summer L; O'Brien E; Nemore P; Hsiao K
Issue Brief (Commonw Fund); 2008 May; 34():1-15. PubMed ID: 18536140
[TBL] [Abstract][Full Text] [Related]
10. Protecting medicare for doctors and seniors.
Frelinghuysen R
MD Advis; 2008; 1(4):16-7. PubMed ID: 21971384
[No Abstract] [Full Text] [Related]
11. What does it mean for patients? The expanded Medicare coverage of immunosuppressive medications.
Thomas C
Nephrol News Issues; 2001 May; Suppl():S15-7. PubMed ID: 12108991
[No Abstract] [Full Text] [Related]
12. Balancing the policy with appropriate patient care.
Stefanacci RG
Manag Care; 2008 Jul; 17(7 Suppl 6):16-9. PubMed ID: 19093335
[TBL] [Abstract][Full Text] [Related]
13. The Quality Incentive Program and how it will influence your practice.
Howard AD
Nephrol News Issues; 2013 Jan; 27(1):20-3. PubMed ID: 23427471
[No Abstract] [Full Text] [Related]
14. Medicare coverage changes force a DM approach to ESRD.
Healthc Demand Dis Manag; 1998 Dec; 4(12):184-6. PubMed ID: 10339124
[TBL] [Abstract][Full Text] [Related]
15. Helping patients with end-stage renal disease.
Kuchta K; VanBuskirk S; Houglum M
Am J Nurs; 2007 May; 107(5):35-6. PubMed ID: 17443073
[No Abstract] [Full Text] [Related]
16. Implications of the Medicare modernization act for the treatment of osteoporosis.
Stefanacci R
Manag Care; 2005 Aug; 14(8 Suppl Osteoporosis):13-7; discussion 21-3. PubMed ID: 18564557
[No Abstract] [Full Text] [Related]
17. Entitlement to Medicare benefits based on end-stage renal disease: final regulation.
Fed Regist; 1978 Sep; 43(189):44801-4. PubMed ID: 10297231
[No Abstract] [Full Text] [Related]
18. JAMA PATIENT PAGE. Medicare.
Rajaram R; Bilimoria KY
JAMA; 2015 Jul; 314(4):420. PubMed ID: 26219069
[No Abstract] [Full Text] [Related]
19. Medicare part D--what doctors need to know.
Stephenson L
Iowa Med; 2005; 95(6):24-5. PubMed ID: 16425707
[No Abstract] [Full Text] [Related]
20. A conflict of responsibility: no patient left behind.
Becker BN
Clin J Am Soc Nephrol; 2010 May; 5(5):744-5. PubMed ID: 20448075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
